当前位置: X-MOL首页全球导师 国内导师 › 付卫明

个人简介

学习经历: 1994.09-1998.07山东师范大学,食品科学与工程,学士 2001.07-2003.07天津大学,生物化工,硕士 2010.08-2012.12香港中文大学,生物医学,博士 工作经历: 1998.08-2001.06山东省济南市轻工业学校,教师 2003.03-2006.12天津天士力药业,研发主管 2007.01-2010.03VeoliawaterSolutionandTechnology(SH),技术经理 2012.03-2012.08美国耶鲁大学药理学,访问学者 2012.12-2016.03广州中国科学院先进技术研究所,实验室主任,副研究员 2016.03-至今南方医科大学药学院,副教授 主要科研课题: 1.国家自然科学基金。81773066。基于调控转录因子FOXA2的长链非编码RNA在肝癌转移复发中的作用及分子机制研究。2018.01-2021.12。主持人 2.广东省自然科学基金。2015A030310139。长链非编码RNAH19调控结肠癌中甲氨蝶呤的耐药性及其分子机理的研究。2015.8~2018.7。主持人 3.广州市科技计划项目。2014J410OO45。调控神经胶质瘤中Trail耐受性的microRNAs及其分子机制的研究。2014.1~2016.6。主持人 4.国家自然科学基金项目。81372450。MiRNA-133a调控神经胶质瘤中TRAIL耐受性及分子机制研究。2014.1~2017.12。第二参与人 5.国家自然科学基金。81201699。沉默原癌基因Bmi-1的microRNAs在原发性肝癌中的功能及分子机制研究。2013.1~2015.12。第二参与人 6.教育部留学人员资助项目。20151312。主持人 授权专利: 1.付卫明、张锦芳、梁岩。一种调控肿瘤对TRAIL耐受性的药物。中国。ZL201310089306.4 2.付卫明、张锦芳。MicroRNA用于制备降低神经胶质瘤对TRAIL耐受性的药物的用途。中国。ZL201410165917.7 3.付卫明、梁伟铖。LincRNA在制备调控甲氨蝶呤肿瘤治疗耐药性的药物中的应用。2013.11。中国。Zl201310611737.2

研究领域

研究方向: 1.天然产物抗肿瘤作用的药理学研究 2.Non-codingRNA 3.干细胞分化

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

代表性论文: LiangWC,RenJL,WongCW,ChanSO,WayeMM,FuWM,ZhangJF.(2018) LncRNA-NEFantagonizedepithelialtomesenchymaltransitionandcancermetastasisviacis-regulatingFOXA2andinactivatingWnt/β-cateninsignaling. Oncogene.37(11):1445-1456. WangSS,FengL,HuBG,LuYF,WangWM,GuoW,SuenCW,JiaoBH,PangJX,FuWM,ZhangJF.(2017).miR-133aPromotesTRAILResistanceinGlioblastomaviaSuppressingDeathReceptor5andActivatingNF-κBSignaling.MolTherNucleicAcids,15;8:482-492. LiuY,WangWM,LuYF,FengL,LiL,PanMZ,SunY,SuenCW,GuoW,PangJX,ZhangJF,FuWM.(2017)Usp5functionsasanoncogeneforstimulatingtumorigenesisinhepatocellularcarcinoma.Oncotarget,6;8(31):50655-50664. LiuY,WangWM,ZouLY,LiL,FengL,PanMZ,LvMY,CaoY,WangH,KungHF,PangJX,FuWM,ZhangJF.(2017)Ubiquitinspecificpeptidase5mediatesHistidine-richproteinHpninducedcellapoptosisinhepatocellularcarcinomathroughP14-P53signaling.Proteomics,17(12). LiuY,LiangY,ZhangJF,FuWM.MicroRNA-133mediatescardiacdiseases:Mechanismsandclinicalimplications.(2017)ExpCellRes.354(2):65-70. WuKF,LiangWC,FengL,PangJX,WayeMM,ZhangJF,FuWM.(2017)H19mediatesmethotrexateresistanceincolorectalcancerthroughactivatingWnt/β-cateninpathway.ExpCellRes.350(2):312-317. LiuMH,ZhangQ,ZhangYH,LuXY,FuWM,HeJY.(2016)ChemicalAnalysisofDietaryConstituentsinRosaroxburghiiandRosasterilisFruits.Molecules,9;21(9). HeJY,ZhangYH,MaN,ZhangXL,LiuMH*,FuWM*.(2016)ComparativeanalysisofmultipleingredientsinRosaroxburghiiandR.sterilisfruitsandtheirantioxidantactivities.JournalofFunctionalFoods,27,29-41. LiuMH,KoCH,MaN,TanPW,FuWM*,HeJY*.(2016)Chemicalprofiles,antioxidantandanti-obesityeffectsofextractofBambusatextilisMcClureleaves.JournalofFunctionalFoods,22,533-546. Wei-ChengLiang#,Wei-MingFu#,Yu-BingWang,Yu-XinSun,Liang-LiangXu,Cheuk-WaWong,KaimingChan,GangLi,MaryMiu-YeeWaye,andJin-FangZhang.(2016)H19activatesWntsignalingandpromotesosteoblastdifferentiationbyfunctioningasacompetingendogenousRNA.ScientificReports.8;6:20121. LiangWC,LiangPP,WongCW,NgTB,HuangJJ,ZhangJF,WayeMM,FuWM*.(2016)CRISPR/Cas9TechnologyTargetingFasGeneProtectsMiceFromConcanavalin-AInducedFulminantHepaticFailure.JCellBiochem.9999;1-7, WangB,GuoJ,FengL,SuenCW,FuWM*,ZhangJF,LiG*.(2016)MiR124suppressescollagenformationofhumantendonderivedstemcellsthroughtargetingegr1.ExpCellRes.1;347(2):360-6. WuKF,LiangWC,FengL,PangJX,WayeMM,ZhangJF,FuWM*.(2016)H19mediatesmethotrexateresistanceincolorectalcancerthroughactivatingWnt/β-cateninpathway.ExpCellRes.350(2):312-317 FuWM,WangWM,JiangHQ,QiW,WanDC,ZhangJF(2016)LongNoncodingRNAHotairMediatedAngiogenesisinNasopharyngealCarcinomabyDirectandIndirectSignalingpathways.Oncotarget.26;7(4):4712-23. LiangWC,FuWM,WangWM,JiangHQ,QiW,WanDC,ZhangJF,WayeMM(2015)TheLncRNAH19PromotesEpithelialtoMesenchymalTransitionbyFunctioningasmiRNAspongesinColorectalCancer.oncotarget.8;6(26):22513-25 FuWM,ZhuX,WangWM,LuYF,HuBG,WangH,LiangWC,WangSS,KoCH,WayeMM,KungHF,LiG,ZhangJF.(2015)HotairMediatesHepatocarcinogenesisthroughSuppressingMiRNA-218ExpressionandActivatingP14andP16Signaling.JHepatology.63(4):886-95. LuYF,ZhangL,WayeMM,FuWM*,ZhangJF*.(2015)MiR-218Mediatestumorigenesisandmetastasis:Perspectivesandimplications.ExpCellRes.15;334(1):173-182.Review HING-LOKWONG,WING-SUMSIU,CHAK-HEIFUNG,CHENGZHANG,WAI-TINGSHUM,XUE-LINZHOU,CLARABIK-SANLAU,JING-FANGZHANG,PING-CHUNGLEUNG,WEI-MINGFU*andCHUN-HAYKO*.(2015)Characteristicsofstemcellsderivedfromratfascia:Invitroproliferativeandmultilineagepotentialassessment.MolecularMedicineReports.11(3):1982-90 FuWM,TangLP,ZhuX,LuYF,ZhangYL,LeeWY,WangH,YuY,LiangWC,KoCH,XuHX,KungHF,ZhangJF.(2015)MiR-218-targeting-Bmi-1mediatesthesuppressiveeffectof1,6,7-trihydroxyxanthoneonlivercancercells.Apoptosis.20(1):75-82 HeJY,MaN,ZhuS,KomatsuK,LiZY,FuWM*.(2015)ThegenusCodonopsis(Campanulaceae):areviewofphytochemistry,bioactivityandqualitycontrol.JNatMed.69(1):1-21 ZhangZL,ZhuXL,GaoZL,LinHL,FuWM*.(2014)Efficiencyof10-yearvaccination(2001-2010)onHepatitisAinTianjin,China.HumVaccinImmunother,10(4). FuWM,WangWM,WangH,ZhangJF.(2014)StaphylococcalEnterotoxinC2PromotesOsteogenesisandStimulatesBoneFractureHealing.ExpCellRes.322(1):202-7 FuWM,WangWM,WangH,ZhuX,LiangY,KungHF,ZhangJF.(2014)1,3,5-Trihydroxy-13,13-dimethyl-2H-pyran[7,6-b]xanthonedirectlytargetsheatshockprotein27inhepatocellularcarcinoma.CellBiolInt.38(2):272-6 MoLN,FuWM,ShuXH,LiCG.(2013)miR-128anditstargetgenesintumorigenesisandmetastasis.ExperimentalCellResearch.ExpCellRes.319(20):3059-64 FuWM,ZhangJF,WangH,XiZC,WangWM,ZhuangP,ChenSC,ChanTM,LeungKS,LuG,XuHX,KungHF.(2012)Heatshockprotein27mediatestheeffectof1,3,5-trihydroxy-13,13-dimethyl-2H-pyran[7,6-b]xanthoneonmitochondrialapoptosisinhepatocellularcarcinoma.Jproteomics,75(15):4833-43. FuWM,ZhangJF,WangH,TanHS,WangWM,ChenSC,ZhuX,ChanTM,TseCM,LeungKS,LuG,XuHX,KungHF.(2012)Apoptosisinducedby1,3,6,7-tetrahydroxyxanthoneinHepatocellularcarcinomaandproteomicanalysis.Apoptosis.17(8):842-51. ZhangJF,HeML,FuWM,WangH,ChenLZ,ZhuX,ChenY,ChenG,LuG,LinMC,KungHF(2011).Primate-specificmiRNA-637InhibitsTumorigenesisinHepatocellularCarcinomabydisruptingStat3signaling.Hepatology.54(6):2137-48.

推荐链接
down
wechat
bug